Janos Szebeni

Prof. Dr. Janos Szebeni is the Head of the Nanomedicine Research and Education Center at Semmelweis University, Budapest, Hungary. With his 40 years of experience in the R&D of liposomes, other drug carrier nano-systems and his expertise in immune-mediated adverse effects of nanomedicines. He advises Acthera on matters relating to toxicology of the HSLs.